These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16273798)

  • 21. Psoriatic arthritis assessment tools in clinical trials.
    Mease PJ; Antoni CE; Gladman DD; Taylor WJ
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii49-54. PubMed ID: 15708937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The International Dermatology Outcome Measures Group: formation of patient-centered outcome measures in dermatology.
    Gottlieb AB; Levin AA; Armstrong AW; Abernethy A; Duffin KC; Bhushan R; Garg A; Merola JF; Maccarone M; Christensen R
    J Am Acad Dermatol; 2015 Feb; 72(2):345-8. PubMed ID: 25486914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.
    Singh JA; Guyatt G; Ogdie A; Gladman DD; Deal C; Deodhar A; Dubreuil M; Dunham J; Husni ME; Kenny S; Kwan-Morley J; Lin J; Marchetta P; Mease PJ; Merola JF; Miner J; Ritchlin CT; Siaton B; Smith BJ; Van Voorhees AS; Jonsson AH; Shah AA; Sullivan N; Turgunbaev M; Coates LC; Gottlieb A; Magrey M; Nowell WB; Orbai AM; Reddy SM; Scher JU; Siegel E; Siegel M; Walsh JA; Turner AS; Reston J
    Arthritis Care Res (Hoboken); 2019 Jan; 71(1):2-29. PubMed ID: 30499259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early Recognition and Treatment Heralds Optimal Outcomes: the Benefits of Combined Rheumatology-Dermatology Clinics and Integrative Care of Psoriasis and Psoriatic Arthritis Patients.
    Soleymani T; Reddy SM; Cohen JM; Neimann AL
    Curr Rheumatol Rep; 2017 Nov; 20(1):1. PubMed ID: 29185062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommendations of the Italian Society for Rheumatology for the use of biologic (TNF-alpha blocking) agents in the treatment of psoriatic arthritis.
    Salvarani C; Olivieri I; Pipitone N; Cantini F; Marchesoni A; Punzi L; Scarpa R; Matucci-Cerinic M;
    Clin Exp Rheumatol; 2006; 24(1):70-8. PubMed ID: 16539822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psoriasis and Psoriatic Arthritis Video Project 2010: a report from the GRAPPA annual meeting.
    Callis Duffin K; Mease PJ
    J Rheumatol; 2011 Mar; 38(3):562-3. PubMed ID: 21362788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimisation of rheumatology indices: dactylitis and enthesitis in psoriatic arthritis.
    Ferguson EG; Coates LC
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-113-7. PubMed ID: 25365099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome measures in psoriatic arthritis.
    Gladman DD; Mease PJ; Krueger G; van der Heidje DM; Antoni C; Helliwell PS; Kavanaugh AF; Nash P; Ritchlin CT; Strand CV; Taylor W
    J Rheumatol; 2005 Nov; 32(11):2262-9. PubMed ID: 16265714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome measures in psoriatic arthritis.
    Gladman DD; Mease PJ; Healy P; Helliwell PS; Fitzgerald O; Cauli A; Lubrano E; Krueger GG; van der Heijde D; Veale DJ; Kavanaugh A; Nash P; Ritchlin C; Taylor W; Strand V
    J Rheumatol; 2007 May; 34(5):1159-66. PubMed ID: 17477479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome Measures in Psoriatic Arthritis.
    Coates L
    Rheum Dis Clin North Am; 2015 Nov; 41(4):699-710. PubMed ID: 26476227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcomes in psoriatic arthritis: A systematic literature review.
    Palominos PE; Gaujoux-Viala C; Fautrel B; Dougados M; Gossec L
    Arthritis Care Res (Hoboken); 2012 Mar; 64(3):397-406. PubMed ID: 22147535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toward Treating to Target in Psoriatic Arthritis.
    Gladman DD
    J Rheumatol Suppl; 2015 Nov; 93():14-6. PubMed ID: 26523047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014.
    Tillett W; Eder L; Goel N; De Wit M; Gladman DD; FitzGerald O; Campbell W; Helliwell PS; Gossec L; Orbai AM; Ogdie A; Strand V; McHugh NJ; Mease PJ
    J Rheumatol; 2015 Nov; 42(11):2198-203. PubMed ID: 25934828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative.
    Gossec L; de Wit M; Kiltz U; Braun J; Kalyoncu U; Scrivo R; Maccarone M; Carton L; Otsa K; Sooäär I; Heiberg T; Bertheussen H; Cañete JD; Sánchez Lombarte A; Balanescu A; Dinte A; de Vlam K; Smolen JS; Stamm T; Niedermayer D; Békés G; Veale D; Helliwell P; Parkinson A; Luger T; Kvien TK;
    Ann Rheum Dis; 2014 Jun; 73(6):1012-9. PubMed ID: 24790067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome measures for psoriasis severity: a report from the GRAPPA 2012 annual meeting.
    Callis Duffin K; Gottlieb AB
    J Rheumatol; 2013 Aug; 40(8):1423-4. PubMed ID: 23908537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a disease severity and responder index for psoriatic arthritis (PsA)--report of the OMERACT 10 PsA special interest group.
    Coates LC; Mumtaz A; Helliwell PS; Mease PJ; Callis-Duffin K; Krueger GG; McHugh NJ; Strand V; Gladman DD; FitzGerald O
    J Rheumatol; 2011 Jul; 38(7):1496-501. PubMed ID: 21724722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimally important difference for patient-reported outcomes in psoriatic arthritis: Health Assessment Questionnaire and pain, fatigue, and global visual analog scales.
    Kwok T; Pope JE
    J Rheumatol; 2010 May; 37(5):1024-8. PubMed ID: 20231193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiative.
    Perez-Chada LM; Cohen JM; Gottlieb AB; Duffin KC; Garg A; Latella J; Armstrong AW; Ogdie A; Merola JF
    Arch Dermatol Res; 2018 Nov; 310(9):701-710. PubMed ID: 30167814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging in peripheral and axial psoriatic arthritis: contributions to diagnosis, follow-up, prognosis and knowledge of pathogenesis.
    Felbo SK; Terslev L; Østergaard M
    Clin Exp Rheumatol; 2018; 36 Suppl 114(5):24-34. PubMed ID: 30296988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current perspectives in the recognition and management of psoriatic arthritis: implications for integrated patient care.
    Ruderman EM
    Am J Manag Care; 2002 Apr; 8(6 Suppl):S171-80. PubMed ID: 11990862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.